Connor, Clark & Lunn Investment Management Ltd. Enzo Biochem Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$2.02 - $3.02 $129,500 - $193,609	-64,109 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.12 - $3.22 $83,873 - $127,392	39,563 Added 161.18%	64,109 $144,000
Q1 2020 May 13, 2020	BUY	$1.82 - $3.87 $44,673 - $94,993	24,546 New	24,546 $62,000
Q4 2019 Feb 12, 2020	SELL	$2.57 - $3.68 $28,719 - $41,124	-11,175 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$3.01 - $4.0 $33,636 - $44,700	11,175 New	11,175 $40,000
Q3 2017 Nov 14, 2017	SELL	$10.45 - $11.44 $217,568 - $238,180	-20,820 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	20,820	20,820 $230,000

Others Institutions Holding ENZ

# of Institutions

Shares Held

15.5M

Call Options Held

2.3K

Put Options Held

Harbert Fund Advisors, Inc. Birmingham, AL

5.18M
Shares

$3.52 Million
3.43% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.53M
Shares

$1.72 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.88M
Shares

$1.28 Million
0.0% of portfolio
Potomac Capital Management, Inc.

1.48M
Shares

$1.01 Million
3.63% of portfolio
Viex Capital Advisors, LLC Sunny Isles Beach, FL

1.33M
Shares

$907,445
9.62% of portfolio

View Full List

About ENZO BIOCHEM INC

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $33.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

More about ENZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account